Look for:

ACORDA THERAPEUTICS INC.


ISIN:
US00484M7002
WKN:
00484M700
2024/04/17 21:38:42
Price
0.339 USD
Difference -10.79% (-0.04)

General attributes

ISINUS00484M7002
SymbolACORQ
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.395 USD
High0.40 USD
Low0.3201 USD
Close (prev. day)0.38 USD
VWAP0.380912 USD
Volume (pcs)45,540
Trading volume17,342.59
Number of trades86
Last size1,000

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/17 21:38:42
Price
0.339 USD
Difference -10.79% (-0.04)

General attributes

ISINUS00484M7002
SymbolACORQ
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)1 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.395 USD
High0.40 USD
Low0.3201 USD
Close (prev. day)0.38 USD
VWAP0.380912 USD
Volume (pcs)45,540
Trading volume17,342.59
Number of trades86
Last size1,000

Performance and Risk

6m1y3y
Perf (%)-96.68%-96.71%-99.60%
Perf (abs.)-9.86-9.97-83.46
Beta2.451.251.09
Volatility265.91207.61158.29
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.444 USD (171,498)
Ø price 30 days | Ø volume 30 days (pcs.)8.048 USD (279,995)
Ø price 100 days | Ø volume 100 days (pcs.)12.427 USD (87,027)
Ø price 250 days | Ø volume 250 days (pcs.)12.722 USD (51,660)
YTD High | date18.000 USD (2024/01/18)
YTD Low | date0.250 USD (2024/04/12)
52 Weeks High | date24.196 USD (2023/05/08)
52 Weeks Low | date0.250 USD (2024/04/12)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2023/06/0221:589.36 EUR0.006
Munich2024/04/1108:020.785 EUR0.001
Frankfurt2023/06/0515:328.423 EUR0.001
FINRA other OTC Issues2024/04/1721:380.339 USD0.0286

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=146849&ID_TYPE_IMAGE_LOGO=2

Contact Details

ACORDA THERAPEUTICS INC.
- -
Skyline Drive 15 10532 Hawthorne, NY
Telefon: +1 914-347-4300
Fax: +1 914-347-4560
E-mail: -

Company Profile

-

Members of Management Board

John KelleyChairman of Board of Directors
Peder JensenMember of Board of Directors
Sandra PanemMember of Board of Directors
John VarianMember of Board of Directors
Lorin RandallMember of Board of Directors
Ron CohenChairman of Managing Board
Andrew R. BlightMember of Executive Committee
Andrew MayerMember of Executive Committee
Burkhard Blank (bis Dezember 2021)Member of Executive Committee
Denise DucaMember of Executive Committee
Kerry ClemMember of Executive Committee
Lauren SabellaMember of Executive Committee
Michael GesserMember of Executive Committee
Neil BelloffMember of Executive Committee
Tierney SaccavinoMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.